Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pere Santamaria

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Clinical Science (London, England : 1979)|May 13, 2006
Lessons on autoimmune diabetes from animal modelsYang Yang, Pere Santamaria
Frontiers in Immunology|May 16, 2022
Gut Microbial Antigenic Mimicry in AutoimmunityNahir Garabatos, Pere Santamaria
Frontiers in Immunology|February 12, 2021
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and DiseasesPau Serra, Pere Santamaria
Nature Biotechnology|February 27, 2019
Antigen-specific therapeutic approaches for autoimmunityPau Serra, Pere Santamaria
Cold Spring Harbor Perspectives in Medicine|September 16, 2024
Autoantigen-Specific Immunotherapies for the Prevention and Treatment of Type 1 DiabetesMark Peakman, Pere Santamaria
Advanced Drug Delivery Reviews|July 27, 2021
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulationYang Yang, Pere Santamaria
Frontiers in Immunology|October 11, 2023
Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cellsEdgar Angelats, Pere Santamaria
Journal of Autoimmunity|February 28, 2004
T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetesYang Yang, Pere Santamaria
Trends in Immunology|November 23, 2005
To 'B' regulated: B cells as members of the regulatory workforcePau Serra, Pere Santamaria
Frontiers in Immunology|October 18, 2013
MHC Class II Polymorphisms, Autoreactive T-Cells, and AutoimmunitySue Tsai, Pere Santamaria
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Clinical Science (London, England : 1979)|May 13, 2006
Lessons on autoimmune diabetes from animal modelsYang Yang, Pere Santamaria
Frontiers in Immunology|May 16, 2022
Gut Microbial Antigenic Mimicry in AutoimmunityNahir Garabatos, Pere Santamaria
Frontiers in Immunology|February 12, 2021
Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and DiseasesPau Serra, Pere Santamaria
Nature Biotechnology|February 27, 2019
Antigen-specific therapeutic approaches for autoimmunityPau Serra, Pere Santamaria
Cold Spring Harbor Perspectives in Medicine|September 16, 2024
Autoantigen-Specific Immunotherapies for the Prevention and Treatment of Type 1 DiabetesMark Peakman, Pere Santamaria
Advanced Drug Delivery Reviews|July 27, 2021
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulationYang Yang, Pere Santamaria
Frontiers in Immunology|October 11, 2023
Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cellsEdgar Angelats, Pere Santamaria
Journal of Autoimmunity|February 28, 2004
T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetesYang Yang, Pere Santamaria
Trends in Immunology|November 23, 2005
To 'B' regulated: B cells as members of the regulatory workforcePau Serra, Pere Santamaria
Frontiers in Immunology|October 18, 2013
MHC Class II Polymorphisms, Autoreactive T-Cells, and AutoimmunitySue Tsai, Pere Santamaria
Pageof 16